AKEBIA THERAPEUTICS, INC. (AKBA) Return on equity 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-16.3%FY2025 · since FY2016: -199.3% → -16.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.3% | — |
| FY2022 | -1801.1% | -1420.1 pp |
| FY2021 | -381.0% | -223.5 pp |
| FY2020 | -157.5% | -86.3 pp |
| FY2019 | -71.2% | -48.6 pp |
| FY2018 | -22.6% | +37.5 pp |
| FY2017 | -60.1% | +139.2 pp |
| FY2016 | -199.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice